Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
Ecopetrol's Reficar wins court judgment in long-running dispute with McDermott
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
Ecopetrol's Reficar wins court judgment in long-running dispute with McDermott
Mar 21, 2024 8:18 PM
Previous page:
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Next page:
Market Chatter: US Postal Service Starts Crack Down on Distributors of Unregulated Vapes
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Market Chatter: US Postal Service Starts Crack Down on Distributors of Unregulated Vapes
Aug 11, 2025
06:19 AM EDT, 08/11/2025 (MT Newswires) -- The US Postal Service or USPS has blocked Demand Vape from using its services in distributing electronic nicotine delivery systems, or ENDS, as the postal office cracks down on distributors of unregulated vapes, Reuters reported Monday, citing the letter USPS sent to Demand Vape. Reuters said unregulated vapes are not approved by the...
Barrick Mining Q2 Adjusted Earnings, Revenue Rise
Aug 11, 2025
06:16 AM EDT, 08/11/2025 (MT Newswires) -- Barrick Mining ( B ) reported Q2 adjusted earnings Monday of $0.47 per share, up from $0.32 a year earlier. Analysts polled by FactSet expected $0.46. Revenue for the quarter ended June 30 was $3.68 billion compared with $3.16 billion a year earlier. Analysts surveyed by FactSet expected $3.61 billion. The company's shares...
Biotech firm Belite Bio's Q2 net loss widens on higher R&D expenses
Aug 11, 2025
Overview * Belite Bio ( BLTE ) completed enrollment in Phase 3 PHOENIX trial for geographic atrophy * Co raised $15 mln in registered direct offering, strengthening financial position * Tinlarebant granted Breakthrough Therapy Designation for Stargardt disease by FDA Outlook * Belite expects DRAGON trial completion by Q4 2025 * Company plans to submit DRAGON trial data for drug...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP